I’m sure many of you have a pet dog. Well, as Rover quietly licks himself in the corner, few would believe that he may hold the key to unlocking the genetic secrets of human disease, as suggested by…
Thank you to everyone who has made contact with the Renal Fellow Network over the past week or so. Your outpouring of love and support has been a great comfort to Nate’s family and friends at this difficult…
It is with great sadness and sorrow that I am writing to inform you of the passing of Nathan Hellman, MD, PhD, and founder of the Renal Fellow Network Blog. I worked with Nathan in the Division of…
Tamm-Horsfall protein (THP), or uromodulin, is a glycoprotein secreted by the renal epithelium, best known as the proteinacious framework of all urinary casts. It’s function in health is an enigma, but prevention of bacterial colonization of the urinary…
Just heard an interesting talk on endothelial dysfunction and its relation to nephrology. One thing I learned is that the vascular endothelium is actually “hairy”, as demonstrated from this electron micrograph (taken from this website). These little hairs…
Meet Jennifer Harman. She is apparently one of the most famous female professional poker players in the world, having done quite well at the prestigious “World Series of Poker” tournament. It turns out she is also a kidney…
How common is contrast nephropathy in the general outpatient setting? When you send one of your outpatients to get a CT scan with iv contrast, what is the real risk? Much of the randomized, controlled trial data on…
As much as kidney transplant outcomes have improved over the decades, we’re not perfect: a sizable group of patients end up transitioning to dialysis therapies after the kidney transplant stops working. What should be done with the allograft…
Warfarin has recently been associated with an increased risk of stroke in ESRD patients with atrial fibrillation. This makes the decision whether to initiate warfarin therapy in dialysis patients with atrial fibrilltion anything but clear cut. Add to…
Last week’s poll results: who should provide funding for large, randomized controlled drug trials? Most respondents (58%) chose the diplomatic answer and said that it should be a combination between government and pharmaceutical companies. I was somewhat surprised…